Day Two

Click on a session title for more details

Doors open for registration


Chairman's opening remarks

Orphan Drug Development in Asia

Stephen Yoo

Gene-correction for rare disease treatments

Stephen Yoo, Chief Medical Officer, ReGenXBio
Dr Xin Jin
Dr Niranjan Nagarajan

OncoIMPACT: A new genome research methodology for oncology and rare disease

Dr Niranjan Nagarajan, Senior Research Scientist, Genome Institute of Singapore

Morning refreshments I Exhibition visit I 1-to-1 Partnering

Cross-sectoral collaboration

Dr Vinod Mattoo

The evolution of orphan drugs development in India

Dr Vinod Mattoo, Medical Director of Cardiovascular and Metabolics at Asia Pacific, Bristol-Myers Squibb
Dr Michelle Dee

Collaborating with the medical community in Singapore

Dr Michelle Dee, Medical Advisor, Novartis

Roundtable discussions

round tables
round tables

Chairman's closing remarks

Networking luncheon I Exhibition visit I 1-to-1 Partnering

last published: 07/May/15 11:27